CD69 and COVID-19: CD69 expression on MAIT cells has shown to be more pronounced in patients with detectable SARS-CoV-2 viremia (80), as well as in those with a more severe disease (80, 81, 84), suggesting a striking association between MAIT cells activation and worse clinical outcome.